已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

鼻咽癌 医学 相伴的 放射治疗 化疗 荟萃分析 肿瘤科 内科学 危险系数 随机对照试验 置信区间 外科
作者
Pierre Blanchard,Anne Lee,Sophie Marguet,Julie Leclercq,Wai Tong Ng,Jun Ma,Anthony T.�C. Chan,Pei‐Yu Huang,E Benhamou,Guopei Zhu,Daniel T. T. Chua,Yong Chen,Hai‐Qiang Mai,Dora L.�W. Kwong,Shie Lee Cheah,James Moon,Yuk Tung,Kwan‐Hwa Chi,George Fountzilas,Li Zhang
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:16 (6): 645-655 被引量:762
标识
DOI:10.1016/s1470-2045(15)70126-9
摘要

A previous individual patient data meta-analysis by the Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group to assess the addition of chemotherapy to radiotherapy showed that it improves overall survival in nasopharyngeal carcinoma. This benefit was restricted to patients receiving concomitant chemotherapy and radiotherapy. The aim of this study was to update the meta-analysis, include recent trials, and to analyse separately the benefit of concomitant plus adjuvant chemotherapy.We searched PubMed, Web of Science, Cochrane Controlled Trials meta-register, ClinicalTrials.gov, and meeting proceedings to identify published or unpublished randomised trials assessing radiotherapy with or without chemotherapy in patients with non-metastatic nasopharyngeal carcinoma and obtained updated data for previously analysed studies. The primary endpoint of interest was overall survival. All trial results were combined and analysed using a fixed-effects model. The statistical analysis plan was pre-specified in a protocol. All data were analysed on an intention-to-treat basis.We analysed data from 19 trials and 4806 patients. Median follow-up was 7·7 years (IQR 6·2-11·9). We found that the addition of chemotherapy to radiotherapy significantly improved overall survival (hazard ratio [HR] 0·79, 95% CI 0·73-0·86, p<0·0001; absolute benefit at 5 years 6·3%, 95% CI 3·5-9·1). The interaction between treatment effect (benefit of chemotherapy) on overall survival and the timing of chemotherapy was significant (p=0·01) in favour of concomitant plus adjuvant chemotherapy (HR 0·65, 0·56-0·76) and concomitant without adjuvant chemotherapy (0·80, 0·70-0·93) but not adjuvant chemotherapy alone (0·87, 0·68-1·12) or induction chemotherapy alone (0·96, 0·80-1·16). The benefit of the addition of chemotherapy was consistent for all endpoints analysed (all p<0·0001): progression-free survival (HR 0·75, 95% CI 0·69-0·81), locoregional control (0·73, 0·64-0·83), distant control (0·67, 0·59-0·75), and cancer mortality (0·76, 0·69-0·84).Our results confirm that the addition of concomitant chemotherapy to radiotherapy significantly improves survival in patients with locoregionally advanced nasopharyngeal carcinoma. To our knowledge, this is the first analysis that examines the effect of concomitant chemotherapy with and without adjuvant chemotherapy as distinct groups. Further studies on the specific benefits of adjuvant chemotherapy after concomitant chemoradiotherapy are needed.French Ministry of Health (Programme d'actions intégrées de recherche VADS), Ligue Nationale Contre le Cancer, and Sanofi-Aventis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
alex发布了新的文献求助10
1秒前
研友_851KE8发布了新的文献求助10
1秒前
1秒前
zfm完成签到 ,获得积分10
2秒前
3秒前
3秒前
3秒前
alex发布了新的文献求助10
3秒前
alex发布了新的文献求助10
3秒前
alex发布了新的文献求助10
3秒前
alex发布了新的文献求助10
3秒前
alex发布了新的文献求助10
4秒前
alex发布了新的文献求助30
4秒前
alex发布了新的文献求助200
4秒前
三块石头发布了新的文献求助10
4秒前
科研小哥的应助被寤念采纳,获得10
7秒前
alex发布了新的文献求助10
7秒前
alex发布了新的文献求助10
7秒前
alex发布了新的文献求助10
7秒前
jinlin完成签到,获得积分10
8秒前
木木完成签到 ,获得积分10
8秒前
9秒前
小何完成签到,获得积分10
12秒前
花花酱完成签到 ,获得积分10
13秒前
我姓张发布了新的文献求助10
13秒前
淡淡的代芙完成签到,获得积分10
14秒前
15秒前
JamesPei的应助被俏皮以旋采纳,获得10
15秒前
16秒前
愉快的妙竹完成签到 ,获得积分10
17秒前
句号关注了科研通微信公众号
17秒前
罗非鱼发布了新的文献求助10
18秒前
19秒前
乐乐完成签到 ,获得积分10
19秒前
19秒前
动听衬衫发布了新的文献求助10
20秒前
我姓张完成签到,获得积分10
21秒前
SciGPT的应助被罗非鱼采纳,获得10
23秒前
李林高完成签到 ,获得积分10
24秒前
金凤发布了新的文献求助10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184619
求助须知:如何正确求助?哪些是违规求助? 9573576
关于积分的说明 21832380
捐赠科研通 7781845
什么是DOI,文献DOI怎么找? 3434399
关于科研通互助平台的介绍 2558498
邀请新用户注册赠送积分活动 2481003